Efficacy and safety of combined doxofylline and salbutamol in treatment of acute exacerbation of chronic obstructive pulmonary disease
Rev. Assoc. Med. Bras. (1992)
;
67(9): 1256-1260, Sept. 2021. tab
Article
in English
| LILACS
| ID: biblio-1351453
ABSTRACT
SUMMARY OBJECTIVE:
The aim of this study was to investigate the efficacy and safety of combined doxofylline and salbutamol in the treatment of acute exacerbation of chronic obstructive pulmonary disease.METHODS:
A total of 68 acute exacerbation of chronic obstructive pulmonary disease patients were randomly divided into control group (34 cases) and experimental group (34 cases), who received the doxofylline treatment and combined doxofylline and salbutamol treatment for 1 week, respectively. During the treatment, the remission time of typical respiratory manifestations was recorded, and the adverse reactions were observed. At the end of treatment, the treatment efficacy was evaluated. Before and after treatment, the pulmonary function indexes and serological indicators were detected.RESULTS:
After treatment, compared with control group, in experimental group, the effective rate of treatment was significantly increased (p<0.05), the remission time of typical respiratory manifestations was significantly shortened (p<0.05), the pulmonary function indexes were significantly improved (p<0.05), the serum high-sensitivity C-reactive protein and cystatin C levels were significantly decreased, respectively (p<0.05), and the serum prealbumin level was significantly increased (p<0.05). In addition, the adverse reaction rate had no significant difference between two groups (p>0.05).CONCLUSIONS:
In the treatment of acute exacerbation of chronic obstructive pulmonary disease, the combined use of doxofylline and salbutamol can quickly relieve the respiratory symptoms, mitigate the pulmonary dysfunction, and reduce the inflammatory response, thus promoting the outcome of patients.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Theophylline
/
Pulmonary Disease, Chronic Obstructive
/
Albuterol
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992)
Year:
2021
Type:
Article
Affiliation country:
China
Institution/Affiliation country:
Shanxi Provincial Peoples Hospital/CN
/
Sozhou Ninth Peoples Hospital/CN
/
The First Affiliated Hospital of Soochow University/CN
Similar
MEDLINE
...
LILACS
LIS